The interferon-gamma response pathway is a targetable driver of FSHD muscular dystrophy progression
Beatrice Biferali, Federica Del Prete, Mara Salomè, Jose Manuel Garcia Manteiga, Reza Alemohammad, Miriam Mombellardo, Maria Pannese, Emanuele Mocciaro, Francesca Torri, İlker Eren, Elisabetta Ferraro, Dicle Ballikaya, Beatrice Ciurli, Arianna Votta, Daniele Campolungo, , Davide Gabellini
This study identifies the IFN-gamma pathway as a therapeutic target for FSHD by showing its role in driving inflammation and disease progression.
bioRxiv · Oct 19, 2026 · PreprintGenetics